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Abstract
Background: The European Project on OSteoArthritis (EPOSA), here presented for the first time, is a collaborative
study involving five European cohort studies on aging. This project focuses on the personal and societal burden and
its determinants of osteoarthritis (OA). The aim of the current report is to describe the purpose of the project, the
post harmonization of the cross-national data and methodological challenges related to the harmonization process
Methods: The study includes data from cohort studies in five European countries (Germany, Italy, the Netherlands,
Spain and the United Kingdom) on older community-dwelling persons aged ≥ 59 years. The study design and
main characteristics of the five cohort studies are described. Post harmonization algorithms are developed by
finding a “common denominator” to merge the datasets and weights are calculated to adjust for differences in age
and sex distribution across the datasets.
Results: A harmonized database was developed, consisting of merged data from all participating countries. In
total, 10107 persons are included in the harmonized dataset with a mean age of 72.8 years (SD 6.1). The female/
male ratio is 53.3/46.7%. Some variables were difficult to harmonize due to differences in wording and categories,
differences in classifications and absence of data in some countries. The post harmonization algorithms are
described in detail in harmonization guidelines attached to this paper.
Conclusions: There was little evidence of agreement on the use of several core data collection instruments, in
particular on the measurement of OA. The heterogeneity of OA definitions hampers comparing prevalence rates of
OA, but other research questions can be investigated using high quality harmonized data. By publishing the
harmonization guidelines, insight is given into (the interpretation of) all post harmonized data of the EPOSA study.
Background
Osteoarthritis (OA) is a process or condition affecting
the joint cartilage and subchondral bone and is fre-
quently accompanied by pain, stiffness, disability and
radiographic changes [1]. It is the most common cause
of chronic pain in older persons and the leading cause
of disability [2]. The prevalence of OA varies across
countries and study populations [3,4]. A review among
29 studies from 14 countries showed a range in preva-
lence of knee and hip OA from 0.5 to 36% [5]. Differ-
ences in prevalence rates between countries can (partly)
be attributed to differences in study population and
research methods used; however, national differences
such as climate or health care may also play a role. In
the literature, prevalence rates have often been based on
general practitioners’ or other medical registries, but not
all OA-patients consult a health care professional [6]
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prevalence rates [7].
The European Project on Osteoarthritis (EPOSA) stu-
dies the personal and societal burden and its determi-
nants of OA in the aging European population using
data from five population-based cohort studies across
Europe. These cohorts include not only persons with
severe OA who receive treatment, but also persons with
( m i l d )O Aw h oh a v en o ts o u g h tc a r e( s of a r ) .E m p h a s i s
lies on the personal consequences (such as quality of life
and social participation) and societal consequences
(such as health care use) of OA. Population-based stu-
dies are important as they provide data on the burden
of the disease in terms of prevalence and impact on
quality of life and health status, thus offering insight
into the need for health care and prevention strategies.
The cohorts involved have not been set up in a stan-
dardized way and different sampling strategies have
been used. The present paper provides a description of
the cohorts included in the project, focuses on the post
harmonization procedures to merge these cross-national
data and describes the methodological challenges
encountered in the process of harmonization. Our pur-
pose is to document the degree to which these post har-
monization efforts have succeeded. Furthermore, this
paper describes to what extent common data collection
instruments have been used and the important similari-
ties and dissimilarities between these instruments. Post
harmonization of OA, ADL limitations and social parti-
cipation are described in detail to illustrate particular
methodological challenges. The complete harmonization
guidelines can be found in additional file 1: Harmoniza-
tion guidelines.
Methods
Study design
T h ed a t ao ff i v ee x i s t i n gl o n g i t u d i n a lc o h o r ts t u d i e s
are combined using post harmonization procedures.
The five cohorts are population based, but vary in
recruitment procedures and measurement instruments
used. Table 1 provides an overview of the main char-
acteristics of the five cohorts. The design and proce-
dures of all five cohort studies have been approved by
the Medical Ethics committee of the respective
institutes.
Study samples
The EPOSA project involves five cohort studies per-
formed in five different countries. While the methodol-
ogy of each cohort is described in detail elsewhere, here
a brief description of their main characteristics is
provided.
Germany is represented by the University of Ulm,
I n s t i t u t eo fE p i d e m i o l o g ya n dM e d i c a lB i o m e t r ya n d
AGAPLESION Bethesda Clinic Ulm. The study on
Activity and Function in the Elderly in Ulm (ActiFE-
Ulm) [8] is embedded in a European funded study on
the prevalence of COPD and asthma (Indicators for
Monitoring COPD and Asthma - IMCA). A random
sample of 7460 persons aged 65 years and over was
selected from the population registers in Ulm, Neu-Ulm
and Alb-Donau-Kreis. The recruitment phase started in
February 2009 and finished in April 2010. In total, 1506
persons agreed to participate in the study. The primary
focus is physical activity (as measured by sensor tech-
nology) and the consequences of physical activity for
cognitive, emotional and social functioning.
Italy is represented by the Department of Medical
and Surgical Sciences, University of Padova, and
National Research Council (CNR), Aging Branch, Insti-
tute of Neuroscience, Padova. The Progetto Veneto
Anziani (ProVA) study was originally designed to
assess the effects of cardiovascular and osteoarticular
diseases on disability [9]. Participants (65+ years, n =
3099) were living in two geographical areas of north-
eastern Italy (Camposampiero and Rovigo) near the
city of Padova in the Veneto region. Participants were
interviewed at home, and invited to the clinic for a
general physical examination and additional diagnostic
tests. Finally, physicians performed a medical chart
review.
The Netherlands is represented by the VU University
Medical Center, EMGO Institute for Health and Care
Research, Amsterdam. Data were used from the Longi-
tudinal Aging Study Amsterdam (LASA) [10], an
ongoing cohort study of predictors and consequences of
changes in physical, cognitive, emotional and social
functioning in older persons. In 1992/93 the first mea-
surement cycle was completed within a random sample
of older persons (55-85 years). The sample was selected
from the population registers in 11 municipalities in the
Netherlands and stratified for age, sex and level of urba-
nization. Each measurement cycle consists of a main
interview, a medical interview (both face-to-face) and a
self-administered questionnaire. For the current study,
data were used from 1669 persons aged 65 years and
older who participated in the fourth measurement cycle
in 2001/2002.
Spain is represented by the Universidad Autónoma de
Madrid Centro Universitario de Salud Pública. The
study included is Ageing in Peñagrande [11]. Partici-
pants (65+) were selected from the Register of Health
District Area in the neighbourhood of Peñagrande,
which is part of the Fuencarral district in Madrid. Of
the 4,244 persons of 65 years and over living in Peña-
grande as of July 31, 2007, a random, age and sex strati-
fied sample of 1250 persons was drawn of whom 1110
were eligible (88.8%) and 814 consented to participate.
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consisted of face-to-face interviews.
The United Kingdom is represented by the University
of Southampton, Southampton General Hospital, MRC
Lifecourse Epidemiology Unit. The Hertfordshire Cohort
Study (HCS) was designed to examine the relationship
between growth in infancy and the subsequent risk of
common adult diseases, including osteoporosis and
osteoarthritis [12]. Potential participants in HCS were
born during 1931-1939 in Hertfordshire, and still lived
there during the period 1998-2003 (n = 8,650). Persons
who consented were visited at home where a structured
questionnaire was administered (n = 3,225). Participants
then attended a local morning clinic where a variety of
investigations were performed (n = 2,997). In 2004/05, a
follow-up clinical study was performed in East Hertford-
shire (n = 966). In 2007, a postal questionnaire enquir-
ing about clinical events over the follow-up period, was
sent to all participants throughout Hertfordshire (n =
2,299). For the current study, data from the baseline
measurement was used from persons who visited the
clinic and who were 65 years and over (n = 1,879).
Harmonization procedure
When various samples are used to study one particular
hypothesis, the problem of heterogeneity between sam-
ples emerges. To cope with these differences, two
approaches are possible: centralized analyses, which
include harmonization of the datasets to create one large
dataset in which the analyses are done, or coordinated
independent analyses, in which the analyses are done in
each dataset and the results per dataset are pooled after-
wards [13]. In the current study, preference was given to
centralized analyses, because this approach enables ana-
lyses of which covariates explain differences between the
countries. Post harmonization guidelines were developed
to overcome the differences in measurement instruments
between the cohorts. The harmonization guidelines used
Table 1 Overview of the main characteristics of the five cohorts included in EPOSA
ActiFE ProVA LASA Peñagrande HCS
Country Germany Italy Netherlands Spain UK
Region Ulm Camposampiero, Rovigo Amsterdam, Zwolle, Oss Peñagrande
(Madrid)
Hertfordshire
Baseline
year
2009 1995-1997 1992-1993 2007-2008 1999-2004
Number of
follow-up
cycles
025 0 2
Year of last
follow-up
cycle
- 2002-2004 2008 - 2007
Sample size
at baseline
1506 3099 3107 814 3225
Recruitment
criteria
Random selection from
municipality registries,
aged 65 years and older,
stratified for age and sex
Random selection from
health district registries,
aged 65 years and older,
stratified for age and sex
Random selection from
municipality registries
stratified for age, sex and
5 years mortality rate
Random selection
from municipality
registries stratified
for age and sex
Participants were born
during 1931-1939 in
Hertfordshire, and still
lived there during 1998-
2003
Baseline
age-range
(years)
65+ 65+ 55-85 65+ 60-72
Baseline age
(years, mean
(SD))
74.7 (6.5) 76.4 (7.8) 70.8 (8.8) 77 (7.6) 67.4 (1.9)
Sex (%
female)
43.5 59.9 57.6 51,5 47.3
Education
(%
secondary
education or
higher)
20.4 11.8 61.1 19.8 5.2
Marital
status (%
married)
65.2 50.0 53.3 63.4 77.8
ActiFE: study on Activity and Function in the Elderly in Ulm, ProVA: Progetto Veneto Anziani study, LASA: Longitudinal Aging Study Amsterdam, Peñagrande:
Ageing in Peñagrande, HCS: Hertfordshire Cohort Study.
Schaap et al. BMC Musculoskeletal Disorders 2011, 12:272
http://www.biomedcentral.com/1471-2474/12/272
Page 3 of 12in the Comparison of Longitudinal European Studies on
Aging (CLESA) project served as an example for the cur-
rent study [14].
Figure 1 shows a schematic presentation of the harmoni-
zation procedures. Data from all cohorts were merged
based on the common denominator available for each
variable if at least three cohorts had the information rela-
tive to that specific measure available. If not all countries
had the same detail of information, detailed information
was lost in the harmonized variable. Alternatively, the
same variable could be created for less than all five but
more than two countries, if this led to preservation of
detailed information. The cohort without detailed infor-
mation was coded as having missing values on this more
detailed variable. Cut-off values for categorization of vari-
ables were based on cut-off values from the literature. If
no cut-off values were available, cut-off values were based
on biological criteria or the distributions in the cohorts.
Figure 1 also lists all harmonized variables of which the
harmonization was successful (i.e. no or very little loss of
information). Although information on radiographic OA
and site-specific clinical OA was available in two cohorts
only, it was included in the harmonized database, as these
are main variables in the assessment of OA.
The involved partners sent all relevant data with vari-
able and value labels in English to the coordinating cen-
ter (VU University Medical Center, Amsterdam, the
Netherlands). The coordinating center then developed
the harmonized dataset in cooperation with the part-
ners. A code book (harmonization guidelines) was made
explaining how the variables were harmonized (see addi-
tional file 1: Harmonization guidelines).
Weighting procedure
Datasets were merged, but sample sizes and age and sex
distributions differed across cohorts due to differences
in recruitment procedures and inclusion criteria. Sample
weights were calculated to adjust for differences in
recruitment procedures and inclusion criteria. The
weights were calculated per sex and per five-year age
category, using the following formula: W = Nexp/Nobs,
with the Nobs being the number of persons in a specific
age/sex category in the cohort, and Nexp being the
number of persons in a specific age/sex category in the
population [14]. The expected number of persons were
derived from the European Standard Population [15].
Nexp for the European population were based on the
numbers for 2001 (average baseline year) and included
Variable X 
Do ≥3 cohorts have data on this variable? 
Look for common denominator:  
- is the same concept measured? 
post-harmonization not possible 
(example: gait pattern only 
available in ActiFE and LASA) 
NO 
YES 
post-harmonization not possible  
(example: social participation: 
objective/subjective measures 
and differences in classification 
across cohorts) 
Look for common denominator:  
- are the response categories overlapping? 
YES 
NO 
Create harmonization algorithm 
by matching the categories and 
allowing for loss of information 
(example: physical activity, 
yes/no)  
NO 
Create harmonization algorithm 
with as little loss of information as 
possible  
YES 
High quality harmonised 
variables: 
 
Demographic variables 
Socio-economic status 
Chronic diseases 
Anthropometry 
Physical performance 
Grip strength 
Pain 
Self perceived health 
Hospitalization 
Figure 1 Schematic presentation of the harmonization process for all non-OA variables.
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based on the numbers for that country given their speci-
fic baseline year.
Results
Description of main characteristics of the cohorts
Table 1 shows the main characteristics of the five
cohorts that were included in the EPOSA study. The
differences in recruitment criteria become evident in the
differences in baseline characteristics of the five cohorts.
Table 2 shows the characteristics of the specific mea-
surement cycle of each cohort that is used in the
EPOSA study. The ActiFE, ProVA, LASA and Peña-
grande studies were similar regarding age distribution,
however, in HCS, the mean age was approximately 10
years lower. In ActiFE and HCS the percentage of men
was higher than in the other studies. Note that the years
of baseline in EPOSA differ across the cohorts. For each
cohort, the most recent measurement cycle that con-
tained comprehensive information on OA was chosen as
the baseline measurement in EPOSA. For example,
2001/02 was chosen as the baseline year in LASA,
because this was the most recent measurement cycle in
which both self-reported and general practitioners infor-
mation on the presence of OA was available.
In this paper it is not possible to describe the harmo-
nization process for all variables included in the EPOSA
database. Please refer to the harmonization guidelines in
additional file 1 for a detailed description of the algo-
rithms used per variable. Here, harmonization of OA,
ADL limitations and social participation is described in
detail to illustrate the challenges and solutions in the
harmonization process.
Harmonization of OA
OA case definitions used in the literature vary by site of
joint involvement (knee, hip, hand, generalised,
unspecified) and by method (self-report, clinical diagno-
sis/classification, plain radiography or other imaging,
combinations of these). Each of these different
approaches to OA case definitions was evident in the
five cohorts, highlighting the lack of accepted standard
case definitions in current European studies. As OA is
believed to be a collection of disorders with shared fea-
tures rather than a single disease entity, several defini-
tions of OA may be the best strategy. Thus, it was
decided not to develop one harmonized variable for OA,
but rather develop several OA variables (site-specific/
non-specific self reported OA, site-specific/non-specific
clinical OA and radiographic OA) which can be used
according to specific research questions. Table 3 shows
which questions or measurements were used to con-
struct the self-reported, clinical and radiographic defini-
tions for knee, hip, hand and non-specific OA in each of
the cohorts. Note that not all definitions were available
for all cohorts. However, because OA is our main vari-
able of interest in this study, we made an exception
regarding the harmonization procedure: all types of OA
definitions were constructed, even when data from only
two countries were present.
In ProVA, persons were classified by physicians as hav-
ing definite, possible or no OA in the knees, hips or
hands. In the other countries, however, dichotomous defi-
nitions for clinical OA were used (yes/no). To test whether
the possible-category in the ProVA data should be inter-
preted as either definite/yes or no, two statistical proce-
dures were used: (1) optimal scaling technique, and (2)
regression models with known OA-correlates. The optimal
scaling technique used is called Princals, which is based on
non-linear factor analysis [16]. This technique quantifies
the distance between the scaling points (i.e. definite, possi-
ble, no). Regression analyses were done to test the associa-
tions with use of pain/anti-inflammatory drugs, physical
performance, ADL limitations, and grip strength (left and
Table 2 Characteristics of the measurement cycles used in EPOSA
ActiFE ProVA LASA Peñagrande HCS
Country Germany Italy Netherlands Spain UK
Year of baseline in EPOSA 2009 1995-1997 2001-2002 2007-2008 1999-2004
Sample size
Invited 7460 4476 2076 1110 7106
Responded 1506 3099 1691 814 2997
Response rate 19.8 69.2 81.5 73.3 42.2
Age (years, mean (SD)) 74.7 (6.5) 76.3 (7.8) 76.4 (8.0) 74.8 (7.2) 65.6 (2.9)
Sex (% female) 43.5 59.9 57.6 59.1 47.3
Education (% secondary education or higher) 20.4 11.7 61.0 22.4 5.2
Marital status (% married) 65.2 49.8 46.4 64.3 77.8
ActiFE: study on Activity and Function in the Elderly in Ulm, ProVA: Progetto Veneto Anziani study, LASA: Longitudinal Aging Study Amsterdam, Peñagrande:
Ageing in Peñagrande, HCS: Hertfordshire Cohort Study.
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showed smaller distances between ‘definite’ and ‘possible’
than between ‘possible’ and ‘no’ for clinical knee, hip and
hand OA (data not shown). Therefore, ‘possible’ was inter-
preted as ‘definite clinical OA’ in the ProVA cohort.
Table 4 presents the prevalence rates for knee, hip,
hand and non-specific OA per definition used. The low-
est site-specific prevalence rate was found for radio-
graphic knee OA in the UK, the highest prevalence rate
was found for clinical knee OA in ProVA. In LASA and
Table 3 Definitions of OA in the cohort studies included in EPOSA
Cohort
ActiFE ProVA
† LASA Peñagrande HCS
‡
Self-reported OA
Knee - Pain or difficulty moving the
knees in the last year? Positive
if yes for > 1 month.
Do you have OA?
If yes: Would you please
tell me if you have
complaints of the knee?
--
Hip - Pain or difficulty moving the
hips in the last year? Positive if
yes for > 1 month.
Do you have OA?
If yes: Would you please
tell me if you have
complaints of the hip?
--
Hand - Pain or difficulty moving the
hands in the last year? Positive
if yes for > 1 month.
Do you have OA?
If yes: Would you please
tell me if you have
complaints of the fingers or
hand/wrist?
--
Non-
specific
- Positive if “yes” on any of the
above
Do you have OA? Have you had pains in
the joints or bones?
Did you visit a doctor
for this problem?
Positive if yes on both
questions.
-
Clinical OA
Knee - Judgement by physician based
on physical examination and
information from medical
records
- - Told by doctor to have knee
OA
Hip - Judgement by physician based
on physical examination and
information from medical
records
-- -
Hand - Judgement by physician based
on physical examination and
information from medical
records
- - Combination of observed
Heberdens nodes by trained
nurse and self-reported hand
pain.
Non-
specific
Has a doctor ever
told you that you
have or had OA/
arthritis?
Positive if “yes” on any of the
above
General practitioners
questionnaire: Has your
patient been diagnosed
with OA?
Diagnosis in general
practitioners’ records
Positive if “yes” on any of the
above
Radiographic OA
Knee - JSN (K&L ≥ 2) + osteophytes - - JSN (K&L ≥ 2) + osteophytes
Hip - - - -
Hand - DIP, PIP of digits 2-3, and CMC
of digit 1:
JSN (K&L ≥ 2) + osteophytes
- - DIP, PIP, CMC of digits 2-5,
and IP:
JSN (K&L ≥ 2) + osteophytes
ActiFE: study on Activity and Function in the Elderly in Ulm, ProVA: Progetto Veneto Anziani, LASA: Longitudinal Aging Study Amsterdam, Peñagrande: Ageing in
Peñagrande, HCS: Hertfordshire Cohort Study, DIP: distal interphalangeal joint, PIP: proximal interphalangeal joint, CMC: carpo-metacarpal joint, IP: interphalangeal
joint, K&L: Kellgren & Lawrence grading.
† In ProVA., all x-rays were taken at the time of the clinic visit, at the same hospital using the same radiographic equipment with standardized procedures, focus
to film distance 100 cm, 55 kV, 8 mA/s. Anteroposterior x-ray of the hip, and weight-bearing anteroposterior and lateral x-rays of both extended knees were
performed in standing position. Standard posterior-anterior radiographs of both hands with palm flat and fingers straight were performed.
‡ In HCS, weight bearing anterior-posterior and lateral semi-flexed radiographs of both knees were taken at the same hospital using the same radiographic
equipment; a standard tube to film distance of 100|cm was used. Radiographs were performed at a median duration of 6|months (interquartile range (IQR) 4.8-
7.2) after the clinic visit. Using the same equipment, anterior-posterior hand radiographs were obtained, with the hand placed as flat as possible.
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65-74 years old
Germany Italy Netherlands Spain UK
Definitions based on self-report
Knee OA - 19.2
(17.1-21.3)
n = 1412
23.6
(20.5-26.7)
n = 706
--
Hip OA - 14.1
(12.3-15.9)
n = 1412
17.4
(14.6-20.2)
n = 706
--
Hand OA - 15.7
(13.8-17.6)
n = 1411
19.1
(16.2-22.0)
n = 706
--
Non-specific - 32.3
(29.9-34.7)
n = 1411
41.4
(37.8-45.0)
n = 735
56.2
(50.8-61.6)
n = 326
-
Definitions based on clinical judgement
Knee OA - 36.7
(34.2-39.2)
n = 1434
- - 18.6
(16.0-21.2)
n = 878
Hip OA - 22.9
(20.7-25.1)
n = 1434
-- -
Hand OA - 33.1
(30.7-35.5)
n = 1433
- - 23.1
(21.1-25.1)
n = 1678
Non-specific 44.7
(41.4-48.1)
N = 830
54.6
(52.0-57.2)
n = 1433
23.7
(20.0-27.4)
n = 510
43.6
(38.2-49.0)
n = 328
29.3
(27.1-31.4)
n = 1688
Definitions based on radiographic information
Knee OA - 8.6
(6.4-10.8)
n = 647
- - 15.1
(11.4-18.8)
n = 360
Hip OA - 3.5
(2.1-4.9)
n = 641
-- -
Hand OA - 31.0
(26.3-35.7)
n = 375
- - 28.1
(19.3-36.9)
n = 100
75+ years old
Germany Italy Netherlands Spain UK
Definitions based on self-report
Knee OA - 24.3
(22.1-26.5)
n = 1436
31.4
(28.0-34.8)
n = 696
--
Hip OA - 18.9
(16.9-20.9)
n = 1436
19.1
(16.2-22.0)
n = 696
--
Hand OA - 21.9
(19.8-24.0)
n = 1436
25.9
(22.6-29.2)
n = 697
--
Non-specific - 40.4
(37.9-42.9)
n = 1433
53.5
(49.9-57.1)
n = 758
65.5
(61.2-69.8)
n = 460
-
Definitions based on clinical judgement
Knee OA - 50.8
(48.4-53.2)
n = 1672
-- -
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to be higher than for clinical OA, however, in Italy, a
reverse pattern was found. The agreement between self-
reported and clinical OA varied between 77 and 82%. In
HCS, prevalence rates were higher for clinical than
radiographic knee OA, but lower for clinical than radio-
graphic hand OA. The agreement between clinical and
radiographic OA was 64% for the hand and 79% for the
knee.
Harmonization of ADL limitations
In all five cohorts, a variety of Activity of Daily Living
(ADL) variables were assessed in structured interviews
(Table 5). First it was investigated which items were
available in all cohorts. The item “do you have difficulty
with walking up and down from a staircase?” was avail-
able in all cohorts and therefore included in the harmo-
nized ADL score. In the LASA study, the item “do you
have difficulty with taking a shower or bath?” was not
Table 4 Prevalence rates of Osteoarthritis (OA) per site, per country and per definition (Continued)
Hip OA - 36.1
(33.8-38.4)
n = 1672
-- -
Hand OA - 44.1
(41.7-46.5)
n = 1674
-- -
Non-specific 47.9
(44.1-51.7)
n = 670
69.6
(67.4-71.8)
n = 1672
40.5
(36.4-44.6)
n = 549
56.6
(52.1-61.1)
n = 468
-
Definitions based on radiographic information
Knee OA - 17.7
(14.7-20.7)
n = 610
-- -
Hip OA - 7.4
(5.3-9.5)
n = 584
-- -
Hand OA - 55.0
(49.8-60.2)
n = 358
-- -
Presented are the prevalence rates and 95% confidence intervals (95%CI) for site-specific and non-specific OA per country and per definition used. 95%CI was
calculated as: p ± 1.96 * SE in which SE = √ (p (1 - p)/n) and p = proportion. Results were weighted for age and sex in the European Standard Population as of
January 1, 2001, and stratified for age.
Table 5 Available items of Activity of Daily Living in each cohort
ADL item ActiFE ProVa LASA Peñagrande HCS
Walk up/down stairs +++ + +
Cut your toe nails +++ - +
Dress/undress +++ + -
Sit down/rise from a chair +++ + -
Walk outside without rest + - + - -
Use own/public transportation + - + + -
Take shower/bath +++ + +
Light housework + - - - -
Walk into room - + - + -
Eating/using cutlery - + - + -
Use toilet - + - + -
Raising arms above head -+ - + +
Use fingers to catch/handle small things -+ - + -
Running to catch a bus - - - + -
Heavy housework - - - + -
Preparing a hot meal - - - + +
Shopping/carrying a bag/weight > 5 kg + + - + +
ActiFE: study on Activity and Function in the Elderly in Ulm, ProVA: Progetto Veneto Anziani study, LASA: Longitudinal Aging Study Amsterdam, Peñagrande:
Ageing in Peñagrande, HCS: Hertfordshire Cohort Study. The items in bold were used to construct the variable “number of ADL limitations” in EPOSA.
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Page 8 of 12available, but a proxy was used from the quality of life
index score of the EQ-5D: “how much difficulty do you
have with washing or dressing yourself?” Subsequently,
this item was available in all cohorts and included in the
harmonized ADL score. Second, it was investigated
which items were available in most cohorts, which
resulted in the selection of seven items in total (see
Table 5). Of these seven items, five items were used and
per item 0 to 2 points were assigned according to the
level of difficulty with that activity (0: no difficulty, 1:
with difficulty, 2: unable to do alone). Thus, an ADL
score ranging from 0-10 was made in all cohorts, but
the actual items used within this score partly differ
across cohorts. However, we tried to match the items as
closely as possible according to the underlying physical
demands. For example, the ActiFE and LASA studies
did not have the item “Do you have difficulty with using
your fingers to catch or handle small objects?”. Instead,
the item “Do you have difficulty cutting your toenails?”
was used, because this activity also requires fine motor
skills of the hands.
Harmonization of social participation
All five cohorts had some information on social partici-
pation. In the ActiFE study the Lubben Social Network
Scale was used, which assesses social isolation in older
adults by measuring perceived social support received
by family and friends. Two examples of items of this
questionnaire are “How many relatives do you see or
hear from at least once a month?” and “How many rela-
tives do you feel at ease with that you can talk about
private matters?”. If social participation is regarded as
an objective measurement of social activity, it is not
possible to include data from ActiFE, as the question-
naire measures self perceived social support rather than
engagement in social activities. In ProVA, Peñagrande,
LASA and HCS, the frequency of participation in social
activities was measured. In HCS the social activity score
was derived from the social health questionnaire which
includes the participation and frequency of 13 activities,
such as positions of office or visiting friends. In Peña-
grande, only two questions were asked regarding the fre-
quency of caring for sick persons and caring for
children. In LASA, respondents were asked whether
they were involved in social organizations such as a
political party or sport club and how often they partici-
pated in activities or meetings of these organizations.
Although the frequency of social activities was assessed
in four cohorts, the response categories varied: e.g. in
ProVA the number of weekly hours devoted to social
activities was asked, while in HCS the response cate-
gories were “weekly”, “monthly” or “less often”.T h u s ,
the number and types of activities and the response
categories differ greatly across the cohorts. It was
therefore concluded that the social participation vari-
ables from the different cohorts were too heterogeneous
to be harmonized.
Discussion
As the percentage of older persons is increasing rapidly
a c r o s st h eW e s t e r nw o r l d ,t h ep r e v a l e n c eo fO Ai s
expected to rise [2]. So far, OA has received little atten-
tion from clinicians and health care organisations. OA
has mainly been studied clinically in a selected patient
population. However, prevalence rates, course and con-
sequences of OA in the general population are still lar-
gely unknown [7]. World-wide large variations exist in
treatment guidelines and timing of joint replacement
surgeries [17,18]. The EPOSA study was initiated to add
to the insight into the correlates of OA and the role of
differences in geographics, socio-economic status, and
health care policies between European countries. Since
OA cannot be cured, insight into the physical, mental
and social consequences of OA is important. Such con-
sequences may be more important outcomes of treat-
ment than disease severity. However, there is a gap in
the literature on these consequences in the general
population. The EPOSA study aims to bridge this gap.
This information will help to improve guidelines for the
treatment of OA and subsequently the quality of life in
OA patients.
In this paper, the harmonization procedures are
described that are used in the European Project on
Osteoarthritis (EPOSA). This study combines data of
existing cohort studies across five European countries
varying in climate, socio-economic status, life style, and
health care policies. Across the cohorts, different mea-
surement instruments were used and post harmoniza-
tion algorithms were needed to merge the datasets and
enable statistical analyses that allow testing cross-coun-
try differences.
Due to the lack in standardization of the definition of
OA, it was impossible to harmonize OA into one vari-
able of OA. However, OA is believed to be a collection
of disorders with shared features rather than a single
disease entity, suggesting that it is appropriate to use
several definitions of OA. Different definitions were con-
structed, based on three sources of information, i.e. self-
report, clinical diagnosis and radiography. Higher rates
of knee, hand and hip OA were found, for self-reported
definitions than for the clinical definitions and radiogra-
phy. These findings suggest that the prevalence rates of
OA are higher for less specific definitions (e.g. pain or
self-report) than for more specific definitions (clinical
judgement by a rheumatologist). The only exception is
the ProVA study, in which the self-reported prevalence
rates were lower than the clinical prevalence rates. This
m a yb ee x p l a i n e db yt h ef a c tt h a tw ei n t e r p r e t e d
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led to an overestimation. If the “possible” category is
interpreted as not having OA, the prevalence rates for
clinical OA are lower than for self-reported OA (data
not shown). In contrast to our findings, a recent review
study showed that prevalence rates were higher when
radiographic OA definition was used compared to symp-
tomatic or self-reported OA definitions (Pereira, 2011).
This study included population based studies as well as
hospital based studies, which makes it difficult to com-
pare these results with the results of our study. The
study also showed the difficulty in drawing conclusions
on pooled prevalence rates due to large differences in
study design, definition of OA and measurement of OA.
A limitation of this study might be the lack of radio-
g r a p h i cO Ad a t ai nm o s tc o h o r t s( o n l ya v a i l a b l ei n
ProVA and HCS), as radiographic OA is still seen as the
standard case definition of OA in many epidemiological
studies [19]. Also the widely used American College of
Rheumatology (ACR) criteria include both clinical
assessment and radiography in the definition of knee,
hip and hand OA [20-22]. These criteria are developed
for patients who report to their doctor with pain. The
EPOSA study however, is completely population based,
including both OA patients (who do not always seek
care) and healthy persons. Performing radiography in
population based studies is not common and often not
feasible.
Despite the harmonization efforts, important differ-
ences remain in the interpretation of the OA-definitions
for each EPOSA cohort. The number of joints included
in the non-specific OA definitions varied (two joints in
HCS, three joints in ProVA, and all joints in LASA and
Peñagrande) and the source of information varied (e.g.
clinical definitions were based on physical examinations
carried out as part of the study in ProVA, on informa-
tion available in medical records in LASA and Peña-
grande, and on self-report of being diagnosed with OA
by a physician in HCS and ActiFE, and self-reported
OA was based on the question “do you have OA?” in
LASA and on reported pain or difficulty moving the
joints (Peñagrande and ProVA). These differences in
definitions hamper cross-country comparisons of preva-
lence rates. The interpretation of the definitions
between countries is too diverse and pre harmonization
is needed to reliably study cross-national differences in
prevalence rates of OA. In the literature, much effort
has been devoted to developing a standard definition of
OA for epidemiologic studies that includes symptoms,
disability, and joint structural disease [23]. A difficulty
in establishing a single definition is that although there
is some correlation between radiographic disease sever-
ity and both symptoms and disability, the relationships
are not as strong as expected [24,25]. The results of
these studies suggest that OA is a collection of disorders
with shared features rather than a single disease entity,
resulting in different OA phenotypes. In our study we
tried to harmonize different OA variables into three
definitions (self-reported, clinical and radiographic OA),
enabling studying different phenotypes of OA, depend-
ing on specific research questions.
Recently, recommendations for standardization of
radiographic OA and symptomatic OA were given by
researchers of the Translational Research in Europe
Applied Technologies for Osteo-Arthritis (TREAT-OA)
consortium, a large study on genetic and biochemical
risk factors of OA [26]. Consensus was reached that
radiographic knee OA should be defined with the origi-
nal Kellgren & Lawrence score “definite osteophytes and
possible joint space narrowing”, which is in agreement
with our study. Radiographic hip OA was defined as “at
least definite joint space narrowing”, and no consensus
was reached for the definition of radiographic hand OA.
It was also not possible to standardize symptomatic OA
since all studies defined symptomatic OA differently.
The authors suggest including pain, clinical assessment
of OA as well as radiographic data in this definition
[26]. Efforts in the development of knee OA definitions
for use in epidemiological studies have led to the
EULAR-recommendations [27], however, the informa-
tion needed for these definitions (symptoms: pain,
morning stiffness and functional limitations and signs:
crepitus, restricted movement and bony enlargement) is
not yet commonly measured in existing cohort studies.
Until common definitions are available in cohort studies,
post harmonization procedures, although not ideal, are
the only available option for cross-cohort comparison of
prevalence rates. Unfortunately, the cross-national
EPOSA dataset is not well suited for research on the
prevalence of OA. However, the dataset can be used to
study associations between OA and risk factors or con-
sequences in one or more cohorts that use a similar OA
definition.
Post harmonization of other instruments other than
OA measures was also problematic. Although a com-
mon ADL limitations measure was constructed, it has to
be tested whether this measure is a valid and reliable
instrument. Loss of information was especially great
regarding social participation. Unfortunately, these data
could not be harmonized because of heterogeneity of
the social activity questionnaires across cohorts.
The measurement instruments used in each of the
cohorts and for all variables were carefully selected by
each of the cohorts and validated instruments were used
if available. However, it is unclear to what degree the
harmonized variables are valid. Validating all con-
structed variables is not feasible. To compensate for
this, we are publishing the harmonization guidelines to
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papers the effect of harmonization on the validity of the
main variables used will be discussed in the concerning
papers.
Fortunately, many other variables were successfully
harmonized and include presence of other chronic dis-
eases, anthropometric measures, physical performance,
grip strength, pain, self perceived health and hospitaliza-
tion. Although the intention of the harmonization was
to study the prevalence rates of OA across countries
and to focus on personal and societal consequences of
OA, we cannot pursue these research questions with the
current harmonized OA data. On the other hand, it is
very well possible to study risk factors and consequences
of OA in a part of the cohorts (based on the research
questions and OA definitions available in the cohorts)
and to study other non-OA-related research questions
using high quality harmonized EPOSA data.
Post harmonization of epidemiologic studies has
become more common in the past 20 years [28]. It is of
great importance to address issues that arise when origi-
nal data are being harmonized. When attempting post
harmonization of data from existing cohort studies the
challenges described in this paper are likely to occur.
Although the cohorts that participate in the EPOSA
study use common data collection instruments, still
large differences in many variables existed due to differ-
ences in wording and categories, differences in classifica-
tions or absence of data. When harmonization leads to
too much loss of information, for example in social par-
ticipation, analysis can be done per cohort. Overall esti-
mates can be obtained by pooling the results. However,
this approach hampers cross-national comparisons and
difficulty with the interpretation of the results remains.
The results of this current paper show the urgency for
more agreement on common data collection instru-
ments in the design stage of cohort studies rather then
retrospectively to facilitate pooling of data and cross-
national comparison.
Despite these issues, the EPOSA dataset provides a
unique opportunity to study various research questions
in general populations of older persons across Europe.
The cross-national nature of the study provides for a
large number of older persons in the analyses and
large variation across cohorts, resulting in sufficient
power to draw conclusions with respect to associations
between variables. The harmonized dataset allows for
analysis on the individual level, and stratified analyses
allow for studying cross-nation differences. In addition,
direct replication of findings across countries is possi-
ble. Four of the cohorts participating in the EPOSA
study provide follow-up data, enabling longitudinal
data analyses.
Despite the extensive harmonization procedure, some
v a r i a b l e s ,i n c l u d i n gO A ,m a yc o n t i n u et ob ed i f f i c u l tt o
compare across countries, and interpretation of findings
may require particular attention. These aspects will be
considered carefully by all involved investigators, and
potential biases in the cross-national comparisons will
be discussed in each future article.
Conclusions
This paper provides the harmonization procedures on
OA and other selected variables of the EPOSA project.
This paper shows the degree of success of the post har-
monization attempts that have been made. Given the
heterogeneity within the OA definitions, this dataset is
less suitable to study prevalence rates of OA. However,
the dataset is suitable for studying other research ques-
tions using high quality harmonized data. Furthermore,
it is recommended that researchers reach agreement on
data collection instruments in the design stage of cohort
studies to facilitate successful pooling of data.
Additional material
Additional file 1: Harmonization guidelines. This file provides all
harmonized variables of the EPOSA study in detail.
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